Literature DB >> 24476345

A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue.

Babita Bisht1, Warren G Darling, Ruth E Grossmann, E Torage Shivapour, Susan K Lutgendorf, Linda G Snetselaar, Michael J Hall, M Bridget Zimmerman, Terry L Wahls.   

Abstract

BACKGROUND: Multiple sclerosis is an autoimmune disease influenced by environmental factors.
OBJECTIVES: The feasibility of a multimodal intervention and its effect on perceived fatigue in patients with secondary progressive multiple sclerosis were assessed. DESIGN/
SETTING: This was a single-arm, open-label intervention study in an outpatient setting.
INTERVENTIONS: A multimodal intervention including a modified paleolithic diet with supplements, stretching, strengthening exercises with electrical stimulation of trunk and lower limb muscles, meditation, and massage was used. OUTCOME MEASURES: Adherence to each component of the intervention was calculated using daily logs. Side-effects were assessed from a monthly questionnaire and blood analyses. Fatigue was assessed using the Fatigue Severity Scale (FSS). Data were collected at baseline and months 1, 2, 3, 6, 9, and 12.
RESULTS: Ten (10) of 13 subjects who were enrolled in a 2-week run-in phase were eligible to continue in the 12-month main study. Of those 10 subjects, 8 completed the study and 6 subjects fully adhered to the study intervention for 12 months. Over a 12-month period, average adherence to diet exceeded 90% of days, and to exercise/muscle stimulation exceeded 75% of days. Nutritional supplements intake varied among and within subjects. Group daily average duration of meditation was 13.3 minutes and of massage was 7.2 minutes. No adverse side-effects were reported. Group average FSS scores decreased from 5.7 at baseline to 3.32 (p=0.0008) at 12 months.
CONCLUSIONS: In this small, uncontrolled pilot study, there was a significant improvement in fatigue in those who completed the study. Given the small sample size and completer rate, further evaluation of this multimodal therapy is warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24476345      PMCID: PMC4011484          DOI: 10.1089/acm.2013.0188

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  28 in total

1.  Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

Authors:  G L Bowman; L C Silbert; D Howieson; H H Dodge; M G Traber; B Frei; J A Kaye; J Shannon; J F Quinn
Journal:  Neurology       Date:  2011-12-28       Impact factor: 9.910

Review 2.  Treatment of fatigue in multiple sclerosis: a systematic review of the literature.

Authors:  David Lee; Robert Newell; Lucy Ziegler; Annie Topping
Journal:  Int J Nurs Pract       Date:  2008-04       Impact factor: 2.066

3.  Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis.

Authors:  Erin M Snook; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2008-10-23       Impact factor: 3.919

Review 4.  Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients.

Authors:  J M Bourre
Journal:  J Nutr Health Aging       Date:  2006 Sep-Oct       Impact factor: 4.075

Review 5.  The effect of exercise therapy on fatigue in multiple sclerosis.

Authors:  A K Andreasen; E Stenager; U Dalgas
Journal:  Mult Scler       Date:  2011-04-05       Impact factor: 6.312

6.  Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.

Authors:  O Andersen; I Elovaara; M Färkkilä; H J Hansen; S I Mellgren; K-M Myhr; M Sandberg-Wollheim; P Soelberg Sørensen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

7.  Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.

Authors:  Valentina Tomassini; Carlo Pozzilli; Emanuela Onesti; Patrizio Pasqualetti; Fabiana Marinelli; Angela Pisani; Cesare Fieschi
Journal:  J Neurol Sci       Date:  2004-03-15       Impact factor: 3.181

8.  Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.

Authors:  Richard A Rudick; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Ernst-Wilhelm Radue; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

Review 9.  Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.

Authors:  William H Stuart
Journal:  Curr Med Res Opin       Date:  2007-04-23       Impact factor: 2.580

Review 10.  Interferon β for secondary progressive multiple sclerosis: a systematic review.

Authors:  Loredana La Mantia; Laura Vacchi; Marco Rovaris; Carlo Di Pietrantonj; George Ebers; Sten Fredrikson; Graziella Filippini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-05       Impact factor: 10.154

View more
  25 in total

Review 1.  Dietary Interventions and Multiple Sclerosis.

Authors:  Ghadah Altowaijri; Allison Fryman; Vijayshree Yadav
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 2.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.

Authors:  Paolo Riccio; Rocco Rossano; Marilena Larocca; Vincenzo Trotta; Ilario Mennella; Paola Vitaglione; Michele Ettorre; Antonio Graverini; Alessandro De Santis; Elisabetta Di Monte; Maria Gabriella Coniglio
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-18

4.  Biological determinants of health: Genes, microbes, and metabolism exemplars of nursing science.

Authors:  Erin P Ferranti; Ruth Grossmann; Angela Starkweather; Margaret Heitkemper
Journal:  Nurs Outlook       Date:  2017-04-12       Impact factor: 3.250

Review 5.  Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health.

Authors:  Jessica Maiuolo; Vincenzo Musolino; Micaela Gliozzi; Cristina Carresi; Federica Scarano; Saverio Nucera; Miriam Scicchitano; Francesca Oppedisano; Francesca Bosco; Roberta Macri; Ernesto Palma; Carolina Muscoli; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

Review 6.  The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.

Authors:  Leah J Mische; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2018-03-17       Impact factor: 3.598

Review 7.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 8.  [New aspects of symptomatic MS treatment: Part 6 - cognitive dysfunction and rehabilitation].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 9.  Exploring Wellness Interventions in Progressive Multiple Sclerosis: an Evidence-Based Review.

Authors:  Myriam Venasse; Thomas Edwards; Lara A Pilutti
Journal:  Curr Treat Options Neurol       Date:  2018-04-10       Impact factor: 3.598

10.  Self-Reported Diet and Health Outcomes of Participants of the CCSVI-Tracking Survey Study.

Authors:  Patricia Grace-Farfaglia
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.